Observational studyMedicine2019

Nucleostemin expression in breast cancer is a marker of more aggressive phenotype and unfavorable patients' outcome: A STROBE-compliant article.

Manal M Sami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.